|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/22 |
| (11) | Number of the document | 1631591 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04753822.8 |
| Date of filing the European patent application | 2004-06-02 | |
| (97) | Date of publication of the European application | 2006-03-08 |
| (45) | Date of publication and mention of the grant of the patent | 2011-12-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2004/017080 |
| Date | 2004-06-02 |
| (87) | Number | WO 2004/108764 |
| Date | 2004-12-16 |
| (30) | Number | Date | Country code |
| 475598 P | 2003-06-04 | US | |
| 858186 | 2004-06-01 | US |
| (72) |
LIN, Ai, Y., US
NEFF, Thomas, B., US
OLIVER, Noelynn, A., US
USINGER, William, R., US
WANG, Qingjian, US
YEOWELL, David, A., US
|
| (73) |
FIBROGEN, INC.,
409 Illinois Street, San Francisco, CA 94158,
US
|
| (54) | CONNECTIVE TISSUE GROWTH FACTOR ANTIBODIES |
| CONNECTIVE TISSUE GROWTH FACTOR ANTIBODIES |